Lexicon Pharmaceuticals Inc (LXRX.OQ)

LXRX.OQ on NASDAQ Stock Exchange Global Select Market

0.86USD
19 Dec 2014
Price Change (% chg)

$-0.04 (-4.42%)
Prev Close
$0.90
Open
$0.89
Day's High
$0.94
Day's Low
$0.85
Volume
2,523,578
Avg. Vol
615,986
52-wk High
$2.04
52-wk Low
$0.80

LXRX.OQ

Chart for LXRX.OQ

About

Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral... (more)

Overall

Beta: 1.81
Market Cap (Mil.): $659.17
Shares Outstanding (Mil.): 724.36
Dividend: --
Yield (%): --

Financials

  LXRX.OQ Industry Sector
P/E (TTM): -- 159.35 38.84
EPS (TTM): -0.22 -- --
ROI: -54.77 -0.82 18.26
ROE: -87.10 -1.98 19.12
Search Stocks

BRIEF-Ipsen and Lexicon sign licensing and commercialization agreement for telotristat etiprate

* Lexicon Pharmaceuticals and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

22 Oct 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks